Status:
RECRUITING
Real World Study of Classic Infectious Disease
Lead Sponsor:
Huashan Hospital
Collaborating Sponsors:
First Affiliated Hospital of Xinjiang Medical University
First Affiliated Hospital of Harbin Medical University
Conditions:
Brucelloses
Epidemic Hemorrhagic Fever
Eligibility:
All Genders
18-75 years
Brief Summary
This study aimed to collect and analyze clinical specimens of patients with classic infectious diseases in the real world. To investigate the epidemiological distribution of classic infectious disease...
Detailed Description
Brucellosis is present in humans and animals in nearly 170 countries and regions around the world. In the 1950s and 1960s, brucellosis was seriously prevalent in China. In the 1970s, the epidemic grad...
Eligibility Criteria
Inclusion
- Brucellosis： Patients with any of the following confirmed the evidence.
- sample culture: Brucella;
- Specific antigen or antibody (IgG or IgM) positive. epidemic hemorrhagic fever：
- 1 specific antibody positive 2 Hantavirus RNA positive kala-azar：
- latent infection: rK39 antibody positive
- patients with the following evidence of kala-azar diagnosis: 1) bone marrow, spleen puncture sample culture: Leishmania; 2) bone marrow, spleen puncture sample smear: Leishmania; 3) clinical symptoms, history of exposure or epidemiology, and positive screening test (rK39 positive)
Exclusion
- Patient history data is incomplete
- HIV antibody positive and AIDS patients
- Patients who participated in other clinical trials during the same period.
- Pregnant, lactating women or women of childbearing age who are ready to conceive.
Key Trial Info
Start Date :
May 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04020536
Start Date
May 13 2020
End Date
June 1 2029
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200040